Europe — EMA

Oxaliplatin Eugia

Oxaliplatin, the active ingredient in Oxaliplatin Eugia, is a platinum‑based chemotherapy agent presented as a sterile solution for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Eugia, is a platinum‑based chemotherapy agent presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer and related solid tumours in adult patients. GNH USA supplies Oxaliplatin Eugia as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Oxaliplatin Eugia as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Oxaliplatin used for?

Oxaliplatin Eugia is used primarily for colorectal cancer treatment pathways, targeting tumour growth and spread.

- Colorectal cancer: Improves disease‑free survival when used in adjuvant chemotherapy regimens. - Gastric cancer: Contributes to tumour response when combined with fluoropyrimidines. - Pancreatic cancer: Used in combination protocols to enhance overall response rates. - Metastatic colorectal cancer: Provides disease control in patients with metastatic disease. - Ovarian cancer: Integrated into multi‑drug regimens for advanced cases. - Peritoneal carcinomatosis: Applied in hyper‑hyper‑

What are the side effects of Oxaliplatin?

The ... .... … ... ... ... .... … … ...

What precautions apply to Oxaliplatin?

...

What does Oxaliplatin interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →